Pay in 4 interest-free payments of $6.17 Learn more
Ships within 48 hours · Estimated delivery Oct 12 - Oct 17
AOD-9604
References to metabolic activity are limited to nonclinical research context only
You may also like Product Description DSIP Peptide | Buy DSIP UK | Research Use Only DSIP Delta Sleep-Inducing Peptide is a naturally occurring amphiphilic nonapeptide (Trp-Ala-Gly-Gly-Asp-Ala-Ser-Gly-Glu, MW 849 Da) first isolated from rabbit cerebral venous blood in 1977 by the Schoenenberger-Monnier group at the University of Basel, found in both free and bound forms in the hypothalamus, limbic system, pituitary, gut, pancreas, and body fluids, that in pre-clinical and limited clinical research demonstrates a uniquely broad neuromodulatory profile promoting delta-wave slow-wave sleep (SWS), modulating corticotropin and GH release, exerting stress-protective and adaptogenic activity, reducing mitochondrial oxidative stress under hypoxia, demonstrating anticonvulsant and antinociceptive activity, accelerating motor research applications post-stroke, and exhibiting geroprotective and anticarcinogenic properties in long-term murine studies making it one of the most pharmacologically diverse endogenous regulatory neuropeptides in the sleep and stress research literature, despite its receptor remaining formally unidentified
Learn more in the TB-500 therapy overview, while keeping the limited human evidence and regulatory uncertainty in view
Dihexa is studied for its proposed capacity to function as a potentiator of hepatocyte growth factor (HGF) at the MET receptor tyrosine kinase, rather than acting as a direct receptor agonist
By reinforcing this barrier, it prevents the translocation of luminal antigens and endotoxins into the bloodstream, a key pathological driver in many chronic inflammatory and autoimmune conditions
US$ 26.78
US$ 29.54
US$ 20.39
US$ 21.86
US$ 26.90
US$ 21.39
